Evidence mapPaperPMID 39628999Full record

ArticleFrontiers in oncology2024

The role and mechanism of "eight famous herbals in Zhejiang" in cancer via network pharmacology and experimental validation.

Ziheng Ni, Hao Zhang, Fengyun Chen, Mengjie Yang, Liting Yang, Yuan Zhou, Xianmin Zhou, Jiayi Guo, Xinyu Rao, Jiaqi Cen and 5 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ziheng Ni *School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Hao Zhang *School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Fengyun ChenSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Mengjie YangSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Liting YangSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Yuan ZhouSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Xianmin ZhouSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Jiayi GuoSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Xinyu RaoSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Jiaqi CenSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Qun LvDepartment of Respiratory Medicine of Affiliated Hospital, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Jianjun WangDepartment of Respiratory Medicine of Affiliated Hospital, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Lailing DuKey Laboratory of Pollution Exposure and Health Intervention of Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China.
Gongxing ChenSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Shuiping LiuSchool of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, some components and active ingredients from the herbal formula "eight famous herbals in Zhejiang" (Zhe-Ba-Wei) have been reported to possess antitumor properties. However, there is still no systemic study on the role and mechanism of Zhe-Ba-Wei in cancer. To systematically investigate the anticancer efficacy of Zhe-Ba-Wei, we first identified 17 reported active ingredients with gene targets associated with various types of tumors. Second, we screened these active ingredients and their responding multiple shared targets by analyzing the convergence of diverse and tumor-specific target sites and identified four crucial active ingredients (ferulic acid, quercetin, rutin, luteolin), which were characterized by 27 overlapping gene targets. Third, these 27 gene targets were subsequently mapped onto the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology term, and among the 27 total potential targets, 12 were involved in plasma membrane function. Fourth, we investigated the binding affinities between the four crucial active ingredients and their potential targets such as EGFR and MET, both of which are well-known oncogenes in various cancers. Subsequently, an investigation of the computational ADMET properties showed that most of these four ingredients exhibited good ADMET properties. Finally, we found that three active ingredients (ferulic acid, luteolin, and quercetin) could inhibit the proliferation of non-small cell lung cancer cells and decrease the protein expression of EGFR in a concentration-dependent manner. All these results shed light on the bioactive components, pharmacological effects, and drug development and utilization of Zhe-Ba-Wei, aiming to provide useful support for its further research and clinical application.

Indexed as

active ingredientscancerdrug targetnetwork pharmacologyZhe-Ba-Wei

Identifiers

PMID39628999
PMCPMC11612504

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.